Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?
Maarouf, Adil, Rico, Audrey, Boutiere, Clemence, Perriguey, Marine, Demortiere, Sarah, Pelletier, Jean, Audoin, Bertrand
Published in Neurology : neuroimmunology & neuroinflammation (01.09.2020)
Published in Neurology : neuroimmunology & neuroinflammation (01.09.2020)
Get full text
Journal Article
Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab
Perriguey, Marine, Maarouf, Adil, Stellmann, Jan-Patrick, Rico, Audrey, Boutiere, Clemence, Demortiere, Sarah, Durozard, Pierre, Pelletier, Jean, Audoin, Bertrand
Published in Neurology : neuroimmunology & neuroinflammation (01.01.2022)
Published in Neurology : neuroimmunology & neuroinflammation (01.01.2022)
Get full text
Journal Article
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis
Graille-Avy, Lisa, Boutiere, Clemence, Rigollet, Camille, Perriguey, Marine, Rico, Audrey, Demortiere, Sarah, Durozard, Pierre, Hilezian, Frederic, Vely, Frederic, Bertault-Peres, Pierre, Pelletier, Jean, Maarouf, Adil, Audoin, Bertrand
Published in Neurology : neuroimmunology & neuroinflammation (01.05.2024)
Published in Neurology : neuroimmunology & neuroinflammation (01.05.2024)
Get full text
Journal Article
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
Claverie, Roxane, Perriguey, Marine, Rico, Audrey, Boutiere, Clemence, Demortiere, Sarah, Durozard, Pierre, Hilezian, Frederic, Dubrou, Clea, Vely, Frederic, Pelletier, Jean, Audoin, Bertrand, Maarouf, Adil
Published in Neurology : neuroimmunology & neuroinflammation (01.09.2023)
Published in Neurology : neuroimmunology & neuroinflammation (01.09.2023)
Get full text
Journal Article